Antiviral Drugs Purchase and Distribution
Awarded Award Notice Posted
- Solicitation number
- 19-100-SOL-00008
- Agency
- Immediate Office of the Secretary Department of Health and Human Services
- Awarded
- to Alvogen, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50119C00050 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Not on record
- Place of performance
- TBD, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice is for a contract awarded by the Department of Health and Human Services to purchase and distribute antiviral drugs. The contract awards the purchase of over 58 million capsules each of oseltamivir 30mg and 75mg, and nearly 2 million capsules of zanamivir 5mg between 2019 to 2023, with the potential for additional purchases up to a maximum value of $186 million. Offerors were invited to propose leveraging existing pharmaceutical supply chains to rapidly distribute these drugs to targeted populations during an influenza pandemic through normal distribution and dispensing channels.
Notice text
9 versions
Update #9 · Latest ·
Awarded Vendors: Alvogen, Inc.. Contract Award Dollar Amount: $301,924,228.69 (Total ceiling $500,000,000.00). Contract Award Date: 2019-08-07.
Update #8 ·
This solicitation is hereby amended on 5/22/2019 to post the final round of questions and answers. Please see attachment to this posting..
Update #7 ·
This solicitation is hereby amended to allow for a further question and answer period following the posting of the updated solicitation. Further instructions are included in an attachment to this solicitation.
Questions are now due no later than 2:00 PM EST on Friday, May 17, 2019. Q & A will be posted to FBO by no later than Wednesday, May 22, 2019.
Questions are to be submitted via email to Natasha Rowland, Contracting Officer, at nrowland@cdc.gov. In the subject block of the email, please use the following identification information: "Solicitation #19-100-SOL-00008 Questions".
The deadline for proposals (hardcopy and electronic) is hereby extended until Tuesday, June 4th at 2 PM EST.
Proposals shall be submitted electronically (via email) and original signed proposal shall be shipped via USPS/UPS/FEDEX/courier to:
Natasha Rowland, Contracting Officer
ASPR/DSNS
2945 Flowers Road, South
Mailstop TY-1, Room 1221
Atlanta, GA 30341
.
Update #6 ·
This solicitation is hereby amended on May 3rd, 2019 in order to extend the deadline for proposal submissions. The deadline is hereby extended until Friday, May 31st at 2 PM Eastern Time. .
Update #5 ·
This solicitation is hereby amended on May 1st, 2019 to:
1. Unarchive this solicitation.
2. Provide an updated/track changed RFP which implements changes to the SOW. It is attached. Please review the entire solicitation for any changes or updates.
3. The Contracting Officer is hereby changed from Tasha McMillian to Natasha Rowland, nrowland@cdc.gov; 770-488-2601.
4. The deadline for proposals is hereby extended to May 8, 2019. Proposals shall be submitted electronically and original signed proposal shall be shipped via USPS/UPS/FEDEX/Courier to:
Natasha Rowland, Contracting Officer
ASPR/DSNS
2945 Flowers Road, South
Mailstop TY-1, Room 1221
Atlanta, GA 30341
.
Update #4 ·
The purpose of this update on 2/27/2019, is to add additional questions and responses via Amendment #3 attached to this solicitation..
Update #3 ·
The Solicitation is hereby amended on February 13, 2019 to allow for the following updates:
1. The period for questions is being extended until 2/22/2019 at 2 PM EST. Responses will be posted by NLT 2/27.
2. The deadline for submission of proposals is being extended until 03/13/2019 at 2 PM EST.
For further information, please see the attachment entitled Amendment #2..
Update #2 ·
The Solicitation is hereby amended on February 8, 2019 to upload Amendment 1 to the Solicitation and the Responses to Questions received as Attachments. No other changes are being made to the Solicitation and responses remain due on 2/25 at 2 PM EST. .
Update #1 ·
The Division of the Strategic National Stockpile (DSNS) is considering the purchase of Oseltamivir 30 & 75mg and Zanamivir 5mg. In addition, the DSNS is interested in leveraging the current pharmaceutical supply chain to rapidly dispense antiviral drugs to a targeted population during an influenza pandemic. For further detials, please see attached RFP.
All questions must be submitted via email to Tasha.McMillian@hhs.gov by no later than 2:00 PM EST on February 1, 2019. Responses will be posted here (FBO) by no later than February 8, 2019.
.
Attachments
| File | Type | Posted |
|---|---|---|
| SNS_Antiviral_Second_Round_of_Q_and_A's.pdf | ||
| Second_round_of_Questions_and_Answers.pdf | ||
| SNS_Antiviral_RFP_SNS_amendment_request_4.22.docx | DOCX document | |
| RFP_19-100-SOL-00008_Amendment_3_QA.pdf | ||
| RFP_19-100-SOL-00008_Amendment_2.pdf | ||
| RFP_19-100-SOL-00008_Questions-Responses.docx | DOCX document | |
| RFP_19-100-SOL-00008_Amendment_1.docx | DOCX document | |
| SNS_Antiviral_RFP_final.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity